Using insulin peptide:MHCII tetramers, the Fife group demonstrated that the number of insulin-targeting CD4+ T cells in peripheral blood of T1D patients correlates with insulin autoantibody titers. Here, CD4 is linked to type 1 diabetes mellitus.